About ADDvise Group
Leading supplier to healthcare and research units
ADDvise Group AB (publ) is a leading supplier of equipment and services to healthcare and research facilities. The Group’s subsidiaries are organized into two business areas: LAB and HEALTHCARE. Sales are global. The Group has a clear acquisition strategy of increasing shareholder value through growth – both geographically and by product range. ADDvise shares are listed on Nasdaq First North Premier.
Our broad competence coupled with our specialized business knowledge, means that we can leverage our expertise to find customer orientated solutions within the Group. We believe this is highly valued by our customers, and it helps us to further develop and nurture our long-term relationships with them.
ADDvise aim to extend, improve and save people’s lives by developing and providing products and services for healthcare and research.
ADDvise’s core values are the basis for all our operations. It is an important starting point for strategic planning and how we work. Our core values are based on the three words; business acumen, decentralized and quality. These are perspectives and attitudes that should permeate how we act internally and externally. It describes and clarifies what is particularly important for us to carry out our mission in the best way and achieve our goals.
We make decisions on a commercial basis for the benefit of the business as a whole. We invest wisely and cost-effectively which creates an excellent foundation for achieving our goals.
We work with a decentralized business model and a strong entrepreneurial spirit. Our subsidiaries’ daily operations and decisions are made locally, close to our customers, suppliers and employees.
We strive to ensure good quality in our work. This creates a competitive business with products and services that provide the conditions to improve, extend and save people’s lives.
ADDvise history timeline
ADDvise was founded.
ADDvise is listed on Nasdaq First North Growth Market
New principal owner; changes to management and board
The board decided on a new growth strategy, focusing on expanding the business through acquisitions. First acquisition; Kebo Labrum
Acquires Tillquist, IM-Medico and Sonesta Medical
Acquires Surgical Tables. First American subsidiaries
Acquires Labrum, Hettich Labinstrument, Germa, Merit Cables, and Sonar
Acquires MRC, MediSuite, GraMedica, SLS, Poly, JTECH, Surplus, Seebreath and CliniChain